Inflammatory Mediators in Gastrointestinal Defense and Injury
暂无分享,去创建一个
[1] C. Koboldt,et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[2] J. Wallace,et al. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity. , 1998, Gastroenterology.
[3] M. Steinhoff,et al. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. , 1998, American journal of physiology. Cell physiology.
[4] S. Nikolaus,et al. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation , 1998, Gut.
[5] M. Respondek,et al. Selective cyclo‐oxygenase‐2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach , 1998, British journal of pharmacology.
[6] N. Davies,et al. Aspirin causes rapid up‐regulation of cyclo‐oxygenase‐2 expression in the stomach of rats , 1997, Alimentary pharmacology & therapeutics.
[7] Y. Miyagi,et al. Expression of trypsin in vascular endothelial cells , 1997, FEBS letters.
[8] J. Wallace,et al. Cytokines in inflammatory bowel disease , 1997, Mediators of inflammation.
[9] J. Hoxie,et al. Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2* , 1997, The Journal of Biological Chemistry.
[10] M. Kasuga,et al. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. , 1997, Gastroenterology.
[11] J. Wallace,et al. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. , 1996, The Journal of clinical investigation.
[12] D. Riendeau,et al. Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. , 1996, Gastroenterology.
[13] M. Hollenberg,et al. Rat proteinase‐activated receptor‐2 (PAR‐2): cDNA sequence and activity of receptor‐derived peptides in gastric and vascular tissue , 1996, British journal of pharmacology.
[14] J. Wallace,et al. The cellular and molecular basis of gastric mucosal defense , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] R. Pounder,et al. Thrombotic vascular risk factors in inflammatory bowel disease. , 1996, Gut.
[16] R. Langenbach,et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.
[17] M. Miller,et al. Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis. , 1995, Gastroenterology.
[18] J. Wallace,et al. Nitric oxide as a mediator of gastrointestinal mucosal injury?—Say it ain't so , 1995, Mediators of inflammation.
[19] P. Kubes,et al. Leukotriene C4/D4 induces P-selectin and sialyl Lewis(x)-dependent alterations in leukocyte kinetics in vivo. , 1995, Circulation research.
[20] D. Rachmilewitz,et al. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. , 1995, Gut.
[21] J. Wallace,et al. A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. , 1995, Gastroenterology.
[22] J. Esplugues,et al. Nitric oxide and sensory afferent neurones modulate the protective effects of low-dose endotoxin on rat gastric mucosal damage. , 1995, European journal of pharmacology.
[23] D. Hommes,et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). , 1995, Gastroenterology.
[24] P. Kubes,et al. Excess nitric oxide does not cause cellular, vascular, or mucosal dysfunction in the cat small intestine. , 1995, The American journal of physiology.
[25] J. Wallace,et al. Impaired vasodilatory responses in the gastric microcirculation of anesthetized rats with secondary biliary cirrhosis. , 1995, Gastroenterology.
[26] C. Hogaboam,et al. The selective beneficial effects of nitric oxide inhibition in experimental colitis. , 1995, The American journal of physiology.
[27] F. Casellas,et al. Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis. , 1995, European journal of gastroenterology & hepatology.
[28] C. Dinarello,et al. The interleuldn-1 family: 10 years of discovery’ , 2004 .
[29] B. Soper,et al. Nitric oxide synthase induction and cytoprotection of rat gastric mucosa from injury by ethanol. , 1994, Canadian journal of physiology and pharmacology.
[30] J. Wallace,et al. Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. , 1994, Gastroenterology.
[31] A. Morelli,et al. Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha. , 1994, Gut.
[32] J. Wallace,et al. A diclofenac derivative without ulcerogenic properties. , 1994, European journal of pharmacology.
[33] J. Wallace,et al. Mast cell activation augments gastric mucosal injury through a leukotriene-dependent mechanism. , 1994, The American journal of physiology.
[34] F. Calzetti,et al. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation , 1994, The Journal of experimental medicine.
[35] J. Wallace,et al. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. , 1994, The American journal of physiology.
[36] T. Macdonald,et al. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. , 1993, Gut.
[37] J. Stamler,et al. Peroxynitrite-induced rat colitis--a new model of colonic inflammation. , 1993, Gastroenterology.
[38] K. Rajewsky,et al. Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.
[39] J. Wallace,et al. Modulation of rat mast cell reactivity by IL-1 beta. Divergent effects on nitric oxide and platelet-activating factor release. , 1993, Journal of immunology.
[40] P. Kubes,et al. Nitric oxide syni hesis inhibition induces leukocyte adhesion via superoxid and mast cells , 2004 .
[41] L. McIntire,et al. Molecular determinants of aspirin-induced neutrophil adherence to endothelial cells. , 1993, Gastroenterology.
[42] J. Wallace,et al. Prostaglandin modulation of the gastric vasculature and mucosal integrity in cirrhotic rats. , 1993, The American journal of physiology.
[43] F. S. Becker,et al. Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. , 1993, Journal of immunology.
[44] G. Striker,et al. Insulin uptake and processing by cultured mouse glomerular endothelial cells. , 1993, The American journal of physiology.
[45] C. Hawkey,et al. Enhanced gastric mucosal leukotriene B4 synthesis in patients taking non-steroidal anti-inflammatory drugs. , 1993, Gut.
[46] Ian G. Charles,et al. Induction of nitric oxide synthase in human chondrocytes. , 1993, Biochemical and biophysical research communications.
[47] R. Eliakim,et al. Intestinal epithelial cells contribute to the enhanced generation of platelet activating factor in ulcerative colitis. , 1993, Gut.
[48] J. Wallace,et al. Capsaicin-induced hyperemia in the stomach: possible contribution of mast cells. , 1992, The American journal of physiology.
[49] J. Wallace,et al. Modulation of leukocyte adhesion in rat mesenteric venules by aspirin and salicylate. , 1992, Gastroenterology.
[50] P. Kubes,et al. Nitric oxide modulates epithelial permeability in the feline small intestine. , 1992, The American journal of physiology.
[51] J. Wallace,et al. Indomethacin-induced leukocyte adhesion in mesenteric venules: role of lipoxygenase products. , 1992, The American journal of physiology.
[52] J. Wallace,et al. Mechanisms underlying the protective effects of interleukin 1 in experimental nonsteroidal anti-inflammatory drug gastropathy. , 1992, Gastroenterology.
[53] S. Stephens,et al. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation , 1992, The Lancet.
[54] J. O'flaherty,et al. Tumor necrosis factor-alpha regulates expression of receptors for formyl-methionyl-leucyl-phenylalanine, leukotriene B4, and platelet-activating factor. Dissociation from priming in human polymorphonuclear neutrophils. , 1991, Journal of immunology.
[55] J. Wallace,et al. Secretagogue-specific effects of interleukin-1 on gastric acid secretion. , 1991, The American journal of physiology.
[56] J. Wallace,et al. Intestinal platelet-activating factor synthesis during Nippostrongylus brasiliensis infection in the rat. , 1991, Journal of lipid mediators.
[57] M. Savage,et al. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. , 1991, Gut.
[58] W. MacNaughton,et al. Mechanisms of platelet-activating factor-induced electrolyte transport in the rat jejunum. , 1991, European journal of pharmacology.
[59] P. Kubes,et al. Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[60] C. Valeri,et al. Thromboxane A2 induces leukotriene B4 synthesis that in turn mediates neutrophil diapedesis via CD 18 activation. , 1991, Microvascular research.
[61] A. Dhillon,et al. Granulomatous vasculitis in Crohn's disease. , 1991, Gastroenterology.
[62] R. Erikson,et al. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[63] G. Chiappara,et al. Effect of indomethacin on the kinetics of tumour necrosis factor alpha release and tumour necrosis factor alpha gene expression by human blood monocytes. , 1991, Pharmacological research.
[64] R. Danner,et al. Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents , 1991, The Journal of experimental medicine.
[65] K. Wu,et al. Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[66] E. Livingston,et al. Sensory neurons mediate protective vasodilatation in rat gastric mucosa. , 1991, The American journal of physiology.
[67] T. Peters,et al. Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors. , 1990, Gut.
[68] Y. Taché,et al. Central action of recombinant interleukin-1 to inhibit acid secretion in rats. , 1990, Gastroenterology.
[69] F. Snyder. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. , 1990, The American journal of physiology.
[70] J. Wallace,et al. Reduction of the severity of experimental gastric and duodenal ulceration by interleukin-1 beta. , 1990, European journal of pharmacology.
[71] J. Wallace,et al. Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence. , 1990, The American journal of physiology.
[72] J. Wallace,et al. Platelet-activating factor mediates gastric damage induced by hemorrhagic shock. , 1990, The American journal of physiology.
[73] J. Wallace,et al. Effects of leukotrienes on susceptibility of the rat stomach to damage and investigation of the mechanism of action. , 1990, Gastroenterology.
[74] R. Lavker,et al. Substance P induces the expression of an endothelial-leukocyte adhesion molecule by microvascular endothelium. , 1990, The Journal of investigative dermatology.
[75] W. Hsueh,et al. Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor. , 1990, The American journal of pathology.
[76] J. Wallace,et al. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. , 1990, The American journal of physiology.
[77] S. Moncada,et al. Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat , 1990, British journal of pharmacology.
[78] J. Raud. Vasodilatation and inhibition of mediator release represent two distinct mechanisms for prostaglandin modulation of acute mast cell‐dependent inflammation , 1990, British journal of pharmacology.
[79] F. Guarner,et al. Participation of thromboxane and other eicosanoid synthesis in the course of experimental inflammatory colitis. , 1990, Gastroenterology.
[80] G. Zimmerman,et al. Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion , 1990, The Journal of cell biology.
[81] J. Bienenstock,et al. Effects of platelet-activating factor on ion transport in isolated rat jejunum. , 1989, The American journal of physiology.
[82] I. Hutcheson,et al. Relationship between PAF-acether and thromboxane A2 biosynthesis in endotoxin-induced intestinal damage in the rat. , 1989, Prostaglandins.
[83] R. Stead,et al. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. , 1989, Gastroenterology.
[84] T. Okumura,et al. Interleukin-1 inhibits the secretion of gastric acid in rats: possible involvement of prostaglandin. , 1989, Biochemical and biophysical research communications.
[85] L. Flohé,et al. Leukotriene formation by human polymorphonuclear leukocytes from endogenous arachidonate. Physiological triggers and modulation by prostanoids. , 1989, Biochemical pharmacology.
[86] R. Eliakim,et al. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. , 1988, Gastroenterology.
[87] R. Macdermott. Granulocytes: The culprit in ischemic damage to the intestine , 1988 .
[88] W. Hsueh,et al. Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. , 1988, The Journal of clinical investigation.
[89] D. Remick,et al. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. , 1988, The Journal of biological chemistry.
[90] J. Wallace. Release of platelet-activating factor (PAF) and accelerated healing induced by a PAF antagonist in an animal model of chronic colitis. , 1988, Canadian journal of physiology and pharmacology.
[91] A. Szczeklik,et al. The effect of six prostaglandins, prostacyclin and iloprost on generation of superoxide anions by human polymorphonuclear leukocytes stimulated by zymosan or formyl-methionyl-leucyl-phenylalanine. , 1987, Biochemical pharmacology.
[92] W. Hsueh,et al. Platelet‐activating factor: an endogenous mediator for bowel necrosis in endotoxemia , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[93] J. Wallace,et al. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists. , 1987, Gastroenterology.
[94] H. Kaufmann,et al. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. , 1987, Annals of internal medicine.
[95] C. Hawkey,et al. Gastric mucosal protection with selective inhibition of thromboxane synthesis. , 1987, Gut.
[96] R. Stead,et al. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[97] C. Hawkey. Synthesis of prostaglandin E2, thromboxane B2 and prostaglandin catabolism in gastritis and gastric ulcer. , 1986, Gut.
[98] J. D. Albert,et al. Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.
[99] W. Hsueh,et al. Release of leukotriene C4 by isolated, perfused rat small intestine in response to platelet-activating factor. , 1986, The Journal of clinical investigation.
[100] J. Larrick,et al. Regulation of macrophage tumor necrosis factor production by prostaglandin E2. , 1986, Biochemical and biophysical research communications.
[101] J. Wallace,et al. Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants. , 1986, Prostaglandins.
[102] J. Wallace,et al. Potent ulcerogenic actions of platelet-activating factor on the stomach , 1986, Nature.
[103] S. Kunkel,et al. Prostaglandins as endogenous mediators of interleukin 1 production. , 1986, Journal of immunology.
[104] C. Hawkey,et al. Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment? , 1985, Gastroenterology.
[105] J. Denburg,et al. Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. , 1985, Journal of immunology.
[106] B. Whittle,et al. Gastric vasoconstrictor actions of leukotriene C4, PGF2 alpha, and thromboxane mimetic U-46619 on rat submucosal microcirculation in vivo. , 1985, The American journal of physiology.
[107] S. Kunkel,et al. Arachidonic acid metabolites regulate interleukin-1 production. , 1985, Biochemical and biophysical research communications.
[108] A. Ayalon,et al. The apical surface of canine chief cell monolayers resists H+ back-diffusion , 1985, Nature.
[109] W. Stenson,et al. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. , 1984, Gastroenterology.
[110] J. Salmon,et al. The source of thromboxane and prostaglandins in experimental inflammation , 1983, British journal of pharmacology.
[111] W. Hsueh,et al. Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin. , 1983, The American journal of pathology.
[112] K. Freund,et al. Inhibition of the n-formylmethionyl-leucyl-phenylalanine induced respiratory burst in human neutrophils by adrenergic agonists and prostaglandins of the E series. , 1981, Canadian journal of physiology and pharmacology.
[113] S. Moncada,et al. Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosa , 1981, Nature.
[114] J. Vane,et al. Inhibition of Prostaglandin Synthetase in Brain explains the Anti-pyretic Activity of Paracetamol (4-Acetamidophenol) , 1972, Nature.
[115] J. Vane,et al. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. , 1971, Nature: New biology.
[116] M. Goldman,et al. Interleukin-10 as a regulatory cytokine induced by cellular stress: molecular aspects. , 1998, International reviews of immunology.
[117] M. Kodama,et al. Effects of a thromboxane A2 receptor antagonist in an animal model of inflammatory bowel disease. , 1997, Digestion.
[118] C. Sternini,et al. Action of sensory neurons in an experimental at colitis model of injury and repair. , 1996, The American journal of physiology.
[119] J. Wallace,et al. Tumor necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence. , 1996, The American journal of physiology.
[120] W. Hsueh,et al. Role of leukocyte beta 2-integrin in PAF-induced shock and intestinal injury. , 1996, The American journal of physiology.
[121] J. Wallace,et al. Markedly reduced intestinal toxicity of a diclofenac derivative. , 1994, Life sciences.
[122] E. Lakatta,et al. Regulation of intracellular free Mg2+ and contraction in single adult mammalian cardiac myocytes. , 1994, The American journal of physiology.
[123] L. Buéno,et al. Platelet-activating factor and interleukin 1 are involved in colonic dysmotility in experimental colitis in rats. , 1993, Gastroenterology.
[124] B. C. Chin,et al. Prostaglandins inhibit inflammatory mediator release from rat mast cells. , 1993, Gastroenterology.
[125] J. Wallace. Gastric ulceration: critical events at the neutrophil--endothelium interface. , 1993, Canadian journal of physiology and pharmacology.
[126] N. Lam,et al. Helicobacter pylori and peptic ulcer disease. , 1993, Clinical pharmacy.
[127] W. Xie,et al. Mitogen‐inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs , 1992 .
[128] J. Wallace,et al. Pathogenesis of NSAID gastropathy: are neutrophils the culprits? , 1992, Trends in pharmacological sciences.
[129] J. Wallace,et al. Mechanisms underlying the protective effects of interleukin-1 in experimental NSAID-gastropathy. , 1992 .
[130] J. Wallace,et al. Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis. , 1992, Gastroenterology.
[131] N. Ling,et al. Interleukin-1 inhibits stress-induced gastric erosion in rats. , 1991, Life sciences.
[132] W. R. Zhang,et al. Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying. , 1991, Life sciences.
[133] E. Masini,et al. Nitric Oxide: A Regulatory Mediator of Mast Cell Reactivity , 1991 .
[134] G. Feuerstein,et al. Neuropeptide Y upregulates the adhesiveness of human endothelial cells for leukocytes. , 1991, Circulation research.
[135] P. Kubes,et al. Platelet-activating factor-induced microvascular dysfunction: role of adherent leukocytes. , 1990, The American journal of physiology.
[136] T. Theoharides,et al. Mast cells: the immune gate to the brain. , 1990, Life sciences.
[137] J. Wallace,et al. Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach. , 1989, Life sciences.
[138] J. Wallace,et al. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. , 1989, Gastroenterology.
[139] J. Wallace,et al. Assessment of the role of platelet-activating factor in an animal model of inflammatory bowel disease. , 1989, Journal of lipid mediators.
[140] C. Nast,et al. In vivo production of leukotriene B4 and leukotriene C4 in rabbit colitis. Relationship to inflammation. , 1987, Gastroenterology.
[141] W. Stenson,et al. Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel disease. , 1985, Gastroenterology.
[142] A. Robert. Antisecretory, antiulcer, cytoprotective and diarrheogenic properties of prostaglandins. , 1976, Advances in prostaglandin and thromboxane research.
[143] W. Hsueh,et al. Release of Leukotriene C 4 by Isolated , Perfused Rat Small Intestine in Response to Platelet-activating Factor , 2022 .
[144] M. Zanetti,et al. Inhibition by prostaglandins of leukotriene B 4 release from activated neutrophils ( chemotaxis / degranulation / superoxide / inflammation , 2022 .